You never heard of “100%” in medicine. The attempt is the most success that we have done to prevent HIV. The medicine is safe, as well (has been approved to treat HIV infection). And only needs to be injected twice a year to give a complete protection. This week, small phase results I tried for Lenacapavir enhances once announced at the conference in San Francisco. This is the beginning “on the journey” Man is designed to test the security security in healthy volunteers. Still, the result of promising: all volunteers still have drugs in blood plasma per year after injection, and at a level of research that shows the HIV infection. I am not very happy about the phase trial, which is usually included in volunteers volunteers and usually not tells us what drugs can do. But this test seems different. Together, Lenacapavir tests can bring us significant steps to stop HIV epidemics. First, Fast Recap. We have prophylactic (prep) drugs (prep) for HIV since 2012, but this should be taken daily or before someone is exposed to the virus. In 2021, the US foods and the US medicine approves the length of the contemporary drugs to prevent HIV. The medicine, Cabotegravir should have been injected with each of the two months. But researchers have been working on drugs that offer longer protection. It can be difficult for people to remember to take a daily pill when they are sick, right while healthy. And the drugs have the attached stigma. “People concern with people who listened to the pills in the bus … or see at the introduction table,” said Moupaltics, “HIV’s development, and HIV clinical development in Gilead Science.
